Oklahoma 2023 Regular Session

Oklahoma House Bill HB1713 Compare Versions

OldNewDifferences
11
22
3-ENGR. H. B. NO. 1713 Page 1 1
3+HB1713 HFLR Page 1
4+BOLD FACE denotes Committee Amendments. 1
45 2
56 3
67 4
78 5
89 6
910 7
1011 8
1112 9
1213 10
1314 11
1415 12
1516 13
1617 14
1718 15
1819 16
1920 17
2021 18
2122 19
2223 20
2324 21
2425 22
2526 23
2627 24
2728
28-ENGROSSED HOUSE
29-BILL NO. 1713 By: Marti of the House
29+HOUSE OF REPRESENTATIVES - FLOOR VERSION
30+
31+STATE OF OKLAHOMA
32+
33+1st Session of the 59th Legislature (2023)
34+
35+COMMITTEE SUBSTITUTE
36+FOR
37+HOUSE BILL NO. 1713 By: Marti of the House
3038
3139 and
3240
3341 Garvin of the Senate
3442
3543
36-An Act relating to pharmacies; defining terms; creating
37-certain requirements; creating a penalty; providing for
38-codification; and declaring an emergency .
44+
45+COMMITTEE SUBSTITUTE
46+
47+An Act relating to pharmacies; defining terms;
48+creating certain requir ements; creating a penalty;
49+providing for codification; and declaring an
50+emergency.
51+
3952
4053
4154
4255 BE IT ENACTED BY THE PEOPLE OF THE STATE O F OKLAHOMA:
4356 SECTION 1. NEW LAW A new sect ion of law to be codified
4457 in the Oklahoma Statutes as Section 6969 of Title 36, unless there
4558 is created a duplication in numbering, reads as follows:
4659 A. As used in this section:
4760 1. "Health benefit plan" means a health benefit plan as defined
4861 pursuant to Section 6060.4 in Title 36 of the Oklahoma Statutes;
4962 2. "Pharmacy benefits manager" means a person that performs
5063 pharmacy benefits management and any other person acting for such
5164 person under a contractual or employment relation ship in the
5265 performance of pharmacy benefits management for a managed -care
53-company, not-for-profit hospital, medical services organization,
54-insurance company, third -party payor, or a health program
55-administered by a state agency; and
56-3. "White bagged drugs" means the distribution o f physician
57-administered medication from a pharmacy, typically a specialty
5866
59-ENGR. H. B. NO. 1713 Page 2 1
67+HB1713 HFLR Page 2
68+BOLD FACE denotes Committee Amendments. 1
6069 2
6170 3
6271 4
6372 5
6473 6
6574 7
6675 8
6776 9
6877 10
6978 11
7079 12
7180 13
7281 14
7382 15
7483 16
7584 17
7685 18
7786 19
7887 20
7988 21
8089 22
8190 23
8291 24
8392
93+company, not-for-profit hospital, medical services organization,
94+insurance company, third -party payor, or a health program
95+administered by a state agency; and
96+3. "White bagged drugs" means the distribution o f physician
97+administered medication from a pharmacy, typically a specialty
8498 pharmacy, to the physician's office, hospital, or clinic for
8599 administration.
86100 B. All health benefit plans and pharmacy benefits managers in
87101 this state shall not refuse to authorize, approve, or pay a
88102 participating provider for providing covered physician-administered
89103 drugs to covered persons.
90104 C. All white bagged drugs distributed in this state shall meet
91105 supply chain security controls set forth by the fede ral Drug Supply
92106 Chain Security Act as amended.
93107 D. A health benefit plan or a pharmacy ben efits manager of a
94108 plan shall not require a covered patient to self -administer an
95109 injectable drug against a health care provider 's recommendation in
96110 accordance with the manufacturer's approved guidelines.
97111 E. Health benefit plans shall not require a covere d patient to
98112 pay additional fees for white bagged drugs beyond cost -sharing
99113 obligations as outlined in the individual 's plan.
100114 F. Providers and health care facilities shall be permitted to
101115 dispense and administer a covered physician -administered drug based
102116 on a patient's best interest, provided that the health care facility
103-or provider that administers the drug shall agree to the terms and
104-conditions of network partici pation and accept, as payme nt in full,
105-reimbursement for the drug at the health insurer 's negotiated
106-contracted rate. The health care facility or provider is prohibited
107-from billing or collecting from the patient any amount in excess of
108117
109-ENGR. H. B. NO. 1713 Page 3 1
118+HB1713 HFLR Page 3
119+BOLD FACE denotes Committee Amendments. 1
110120 2
111121 3
112122 4
113123 5
114124 6
115125 7
116126 8
117127 9
118128 10
119129 11
120130 12
121131 13
122132 14
123133 15
124134 16
125135 17
126136 18
127137 19
128138 20
129139 21
130140 22
131141 23
132142 24
133143
144+or provider that administers the drug shall agree to the terms and
145+conditions of network partici pation and accept, as payme nt in full,
146+reimbursement for the drug at the health insurer 's negotiated
147+contracted rate. The health care facility or provider is prohibited
148+from billing or collecting from the patient any amount in excess of
134149 or in addition to the patient 's cost sharing obligations as outlined
135150 in the individual's plan.
136151 G. Any payor in violation of this act shall be fined a minimum
137152 of Five Thousand Dollars ($5,000.00) per violation, but not more
138153 than Ten Thousand Dollars ($10,000.00) per violation. Fines related
139154 to this section shall not be used when calculating payors, plans, or
140155 members loss ratios and losses incurred pursuant to this subsection
141156 shall not be passed on to the consumer in future rate increas es.
142157 SECTION 2. It being immediately necessary for t he preservation
143158 of the public peace, health or safety, an emergency is hereby
144159 declared to exist, by reason whereof this act shall take effect and
145160 be in full force from and after its passa ge and approval.
146-Passed the House of Representatives the 21st day of March, 2023.
147161
148-
149-
150-
151- Presiding Officer of the House
152- of Representatives
153-
154-
155-Passed the Senate the ____ day of __________, 2023.
156-
157-
158-
159-
160- Presiding Officer of the Senate
161-
162-
162+COMMITTEE REPORT BY: COMMITTEE ON INSURANCE, dated 03/01/2023 - DO
163+PASS, As Amended and Coauthored.